Emerging applications of stereotactic radiotherapy in head and neck cancer

Neurosurgical Focus

Volumn 27, Issue 6, 2009, Pages

  Truong, Minh Tam ^a   Grillone, Gregory ^a   Tschoe, Christine ^a   Chin, Lawrence ^a   Kachnic, Lisa Ann ^a   Jalisi, Scharukh ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dose escalation; Head and neck cancer; Reirradiation; Stereotactic body radiotherapy; Stereotactic radiosurgery

Indexed keywords

ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED SURGERY; HEAD AND NECK TUMOR; HUMAN; METHODOLOGY; MULTIMODALITY CANCER THERAPY; RADIATION DOSE; RADIOSURGERY; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SURGERY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 73349112875     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2009.9.FOCUS09199     Document Type: Article

References (64)

1. Adler JR Jr, Chang SD, Murphy MJ, Doty J, Geis P, Hancock SL. The Cyberknife: a frameless robotic system for radiosurgery. Stereotact Funct Neurosurg, 69, 124-128, 1997
2. Adler JR Jr, Murphy MJ, Chang SD, Hancock SL. Imageguided robotic radiosurgery. Neurosurgery, 44, 1299-1307, 1999
3. Ahn YC, Lee KC, Kim DY, Huh SJ, Yeo IH, Lim DH, et al. Fractionated stereotactic radiation therapy for extracranial head and neck tumors. Int J Radiat Oncol Biol Phys, 48, 501- 505, 2000
4. Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol, 16, 1310-1317, 1998
5. American Cancer Society: Cancer Facts and Figures 2009. Atlanta: American Cancer Society, 2009
6. Barrett WL, Gleich L, Wilson K, Gluckman J. Organ preservation with interstitial radiation for base of tongue cancer. Am J Clin Oncol, 25, 485-488, 2002
7. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med, 350, 1945-1952, 2004
8. Bjordal K, de Graeff A, Fayers PM, Hammerlid E, van Pottelsberghe C, Curran D, et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. Eur J Cancer, 36, 1796-1807, 2000
9. Bolner A, Mussari S, Fellin G, Pani G, Busana L, Caffo O, et al. The role of brachytherapy in the management of oropharyngeal carcinomas: the Trento experience. Tumori, 88, 137-141, 2002
10. Bonner JA, Giralt J, Harari PM, Cohen R, Jones C, Sur RK. Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: A phase III study of high dose radiation therapy with or without cetuximab. J Clin Oncol, 22 (Suppl), 5507, 2004
11. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med, 354, 567-578, 2006
12. Brianzoni E, Rossi G, Ancidei S, Berbellini A, Capoccetti F, Cidda C, et al. Radiotherapy planning: PET/CT scanner performances in the definition of gross tumour volume and clinical target volume. Eur J Nucl Med Mol Imaging, 32, 1392- 1399, 2005
13. Buatti JM, Friedman WA, Bova FJ, Mendenhall WM. Linac radiosurgery for locally recurrent nasopharyngeal carcinoma: rationale and technique. Head Neck, 17, 14-19, 1995
14. Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst, 91, 2081-2086, 1999
15. Chao KS, Ozyigit G, Tran BN, Cengiz M, Dempsey JF, Low DA. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys, 55, 312-321, 2003
16. Chua DT, Sham JS, Hung KN, Leung LH, Cheng PW, Kwong PW. Salvage treatment for persistent and recurrent T1-2 nasopharyngeal carcinoma by stereotactic radiosurgery. Head Neck, 23, 791-798, 2001
17. Chua DT, Sham JS, Kwong PW, Hung KN, Leung LH. Linear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma, efficacy and complications. Int J Radiat Oncol Biol Phys, 56, 177-183, 2003
18. Cmelak AJ, Cox RS, Adler JR, Fee WE Jr, Goffinet DR. Radiosurgery for skull base malignancies and nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 37, 997-1003, 1997
19. Conroy T, Mercier M, Bonneterre J, Luporsi E, Lefebvre JL, Lapeyre M, et al. French version of FACT-G: validation and comparison with other cancer-specific instruments. Eur J Cancer, 40, 2243-2252, 2004
20. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med, 350, 1937-1944, 2004
21. Cooper JS, Pajak TF, Rubin P, Tupchong L, Brady LW, Leibel SA, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys, 17, 449-456, 1989
22. Creak AL, Harrington K, Nutting C. Treatment of recurrent head and neck cancer. re-irradiation or chemotherapy? Clin Oncol (R Coll Radiol), 17, 138-147, 2005
23. Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol, 22, 69- 76, 2004
24. Emami B, Sethi A, Petruzzelli GJ. Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 57, 481-488, 2003 25.
25. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med, 349, 2091-2098, 2003
26. Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys, 48, 7-16, 2000
27. Gardner M, Halimi P, Valinta D, Plantet MM, Alberini JL, Wartski M, et al. Use of single MRI and 18F-FDG PET-CT scans in both diagnosis and radiotherapy treatment planning in patients with head and neck cancer: advantage on target volume and critical organ delineation. Head Neck, 31, 461- 467, 2009
28. Gibbs IC, Le QT, Shah RD, Terris DJ, Fee WE, Goffinet DR. Long-term outcomes after external beam irradiation and brachytherapy boost for base-of-tongue cancers. Int J Radiat Oncol Biol Phys, 57, 489-494, 2003
29. Gleich LL, Ryzenman J, Gluckman JL, Wilson KM, Barrett WL, Redmond KP. Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: is salvage possible? Arch Otolaryngol Head Neck Surg, 130, 35-38, 2004
30. Hara W, Loo BW Jr, Goffinet DR, Chang SD, Adler JR, Pinto HA, et al. Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 71, 393-400, 2008
31. Haraf DJ, Weichselbaum RR, Vokes EE. Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease. Ann Oncol, 7, 913-918, 1996
32. Harrison LB, Zelefsky MJ, Sessions RB, Fass DE, Armstrong JG, Pfister DG, et al. Base-of-tongue cancer treated with external beam irradiation plus brachytherapy: oncologic and functional outcome. Radiology, 184, 267-270, 1992
33. Heron DE, Andrade RS, Flickinger J, Johnson J, Agarwala SS, Wu A, et al. Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: a brief technical report. Int J Radiat Oncol Biol Phys, 60, 1419-1424, 2004
34. Heron DE, Ferris RL, Karamouzis M, Andrade RS, Deeb EL, Burton S, et al. Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase i dose-escalation trial. Int J Radiat Oncol Biol Phys [epub ahead of print], 2009
35. Heron DE, Smith RP, Andrade RS. Advances in image-guided radiation therapy-the role of PET-CT. Med Dosim, 31, 3-11, 2006
36. Hoffman HT, Karnell LH, Funk GF, Robinson RA, Menck HR. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg, 124, 951- 962, 1998
37. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin, 56, 106-130, 2006
38. Karakoyun-Celik O, Norris CM Jr, Tishler R, Mahadevan A, Clark JR, Goldberg S, et al. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base. Head Neck, 27, 353-361, 2005
39. Kasperts N, Slotman B, Leemans CR, Langendijk JA. A review on re-irradiation for recurrent and second primary head and neck cancer. Oral Oncol, 41, 225-243, 2005
40. Kuo JS, Yu C, Petrovich Z, Apuzzo ML. The CyberKnife stereotactic radiosurgery system: description, installation, and an initial evaluation of use and functionality. Neurosurgery, 53, 1235-1239, 2003
41. Laccourreye O, Weinstein G, Brasnu D, Bassot V, Cauchois R, Jouffre V, et al. A clinical trial of continuous cisplatinfluorouracil induction chemotherapy and supracricoid partial laryngectomy for glottic carcinoma classified as T2. Cancer, 74, 2781-2790, 1994
42. Le QT, Tate D, Koong A, Gibbs IC, Chang SD, Adler JR, et al. Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 56, 1046-1054, 2003
43. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst, 88, 890-899, 1996
44. Leung TW, Tung SY, Sze WK, Sze WM, Wong VY, Wong CS, et al. Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 48, 1331- 1338, 2000
45. Liao J, Judson B, Davidson B, Amin A, Gagnon G, Harter K. Cyberknife fractionated stereotactic radiosurgery for the treatment of primary and recurrent head and neck cancer. Int J Radiat Oncol Biol Phys, 63 (1 Suppl), S381, 2005
46. Linthout N, Verellen D, Tournel K, Storme G. Six dimensional analysis with daily stereoscopic x-ray imaging of intrafraction patient motion in head and neck treatments using five points fixation masks. Med Phys, 33, 504-513, 2006
47. Mehanna HM, Morton RP. Patients' views on the utility of quality of life questionnaires in head and neck cancer: a randomised trial. Clin Otolaryngol, 31, 310-316, 2006
48. Nishioka T, Shiga T, Shirato H, Tsukamoto E, Tsuchiya K, Kato T, et al. Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys, 53, 1051- 1057, 2002
49. Pai PC, Chuang CC, Wei KC, Tsang NM, Tseng CK, Chang CN. Stereotactic radiosurgery for locally recurrent nasopharyngeal carcinoma. Head Neck 24, 748-753, 2002
50. Poon D, Yap SP, Wong ZW, Cheung YB, Leong SS, Wee J, et al. Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 59, 1312-1318, 2004
51. Roh KW, Jang JS, Kim MS, Sun DI, Kim BS, Jung SL, et al. Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer. Int J Radiat Oncol Biol Phys, 74, 1348-1355, 2009
52. Siddiqui F, Patel M, Khan M, McLean S, Dragovic J, Jin JY, et al. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region. Int J Radiat Oncol Biol Phys, 74, 1047-1053, 2009
53. Spencer S, Wheeler R, Peters G, Meredith R, Beenken S, Nabel L, et al. Phase 1 trial of combined chemotherapy andreirradiation for recurrent unresectable head and neck cancer. Head Neck, 25, 118-122, 2003
54. Spencer SA, Harris J, Wheeler RH, Machtay M, Schultz C, Spanos W, et al. RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys, 51, 1299-1304, 2001
55. Spencer SA, Wheeler RH, Peters GE, Beenken SW, Meredith RF, Smith J, et al. Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck. Am J Clin Oncol, 22, 1-5, 1999
56. Sprangers MA, Cull A, Groenvold M, Bjordal K, Blazeby J, Aaronson NK. The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. Qual Life Res, 7, 291-300, 1998
57. Stevens KR Jr, Britsch A, Moss WT. High-dose reirradiation of head and neck cancer with curative intent. Int J Radiat Oncol Biol Phys, 29, 687-698, 1994
58. Tate DJ, Adler JR Jr, Chang SD, Marquez S, Eulau SM, Fee WE, et al. Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control. Int J Radiat Oncol Biol Phys, 45, 915-921, 1999
59. Voynov G, Heron DE, Burton S, Grandis J, Quinn A, Ferris R, et al. Frameless stereotactic radiosurgery for recurrent head and neck carcinoma. Technol Cancer Res Treat, 5, 529-535, 2006
60. Weinstein GS, El-Sawy MM, Ruiz C, Dooley P, Chalian A, El-Sayed MM, et al. Laryngeal preservation with supracricoid partial laryngectomy results in improved quality of life when compared with total laryngectomy. Laryngoscope, 111, 191- 199, 2001
61. Wong LY, Wei WI, Lam LK, Yuen AP. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck, 25, 953-959, 2003
62. Xiao J, Xu G, Miao Y. Fractionated stereotactic radiosurgery for 50 patients with recurrent or residual nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 51, 164-170, 2001
63. Yau TK, Sze WM, Lee WM, Yeung MW, Leung KC, Hung WM, et al. Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma. Head Neck, 26, 1024-1030, 2004
64. Young H, Baum R, Cremerius U, Herholz K, Hoekstra O, Lammertsma AA, et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. Eur J Cancer, 35, 1773-1782, 1999